60
Participants
Start Date
September 19, 2024
Primary Completion Date
September 10, 2025
Study Completion Date
October 20, 2025
remimazolam combined with remifentanil
Patients in this group will receive a bolus of remimazolam 5 mg intravenously, and then a dose of 0.1 μg/kg/min remifentanil and 0.5 mg/kg/h remimazolam via separate syringe pumps.
dexmedetomidine combined with remifentanil
Patients in this group will receive a loading dose of dexmedetomidine 1 μg/kg over 10 minutes intravenously, and then a dose of 0.1 μg/kg/min remifentanil and 0.5 μg/kg/h dexmedetomidine via separate syringe pumps.
RECRUITING
Nanjing First Hospital, Nanjing
Nanjing First Hospital, Nanjing Medical University
OTHER